High expression of TMEM180, a novel tumour marker, is associated with poor survival in stage III colorectal cancer

BACKGROUND: Transmembrane protein 180 (TMEM180) is a newly identified colorectal cancer (CRC)-specific molecule that is expressed very rarely in normal tissue and up-regulated under hypoxic conditions. We developed a monoclonal antibody (mAb) against TMEM180 and decided to examine the medical signif...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiraishi, Takuya, Ikeda, Koji, Tsukada, Yuichiro, Nishizawa, Yuji, Sasaki, Takeshi, Ito, Masaaki, Kojima, Motohiro, Ishii, Genichiro, Tsumura, Ryo, Saijou, Sinji, Koga, Yoshikatsu, Yasunaga, Masahiro, Matsumura, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989078/
https://www.ncbi.nlm.nih.gov/pubmed/33757462
http://dx.doi.org/10.1186/s12885-021-08046-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989078/
https://www.ncbi.nlm.nih.gov/pubmed/33757462
http://dx.doi.org/10.1186/s12885-021-08046-6

Ejemplares similares